According to a market report by Lucintel, the future of the global prenatal testing & newborn screening market looks promising with opportunities in the hospital and diagnostic center markets. The global prenatal testing & newborn screening market is expected to reach an estimated $18 billion by 2031 with a CAGR of 11.3% from 2025 to 2031. The major drivers for this market are the growing prevalence of genetic disorders and rising cases of chromosome syndrome in babies.
A more
than 150-page report to understand trends, opportunity and forecast in global prenatal
testing & newborn screening market to 2031 by diagnostic type (invasive and
non-invasive), technology (screening technology and diagnostic technology), end
use (hospitals, diagnostic centers, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the diagnostic type category, non-invasive is expected
to witness a higher growth over the forecast period due to its capacity to
impose no risk to the fetus and lower the chance of miscarriage.
Within the
end use category, hospital is expected to witness a higher growth over the
forecast perioddue to growing patients preference for this facility to make
informed decisions.
Download
sample by clicking on prenatal
testing & newborn screening market.
In terms
of region, North America is expected to witness the highest growth over the
forecast period due to growing number of genetic disorders cases and presence
of favorable reimbursement policy in the region.
Perkinelmer,
Natera, Invitae, Centogene, Cradle Genomics, Hoffmann-La Roche, Quest
Diagnostics, Baebies, Ravgen, Eurofins Scientific are the major suppliers in
the prenatal testing &
newborn screening market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Colorant for Synthetic Leather Market
Modified Novolac Epoxy Resin Market
VLP Ultra Low Profile Copper Foil Market
No comments:
Post a Comment